$DXCM
DEXCOM INC

2013 Form 10-K Financial Statement

#000109355714000028 Filed on February 20, 2014

View on sec.gov

Income Statement

Concept 2013 2012 Q4 2012 Q3
Revenue $160.0M $33.30M $23.10M
YoY Change 60.16% 48.66% 26.23%
Cost Of Revenue $59.90M $15.70M $14.70M
YoY Change 12.38% 34.19% 45.69%
Gross Profit $100.1M $17.50M $8.400M
YoY Change 114.81% 63.55% 2.44%
Gross Profit Margin 62.56% 52.55% 36.36%
Selling, General & Admin $84.20M $17.20M $15.40M
YoY Change 31.56% 25.55% 16.31%
% of Gross Profit 84.12% 98.29% 183.33%
Research & Development $44.80M $8.700M $10.30M
YoY Change 16.97% -5.43% 25.14%
% of Gross Profit 44.76% 49.71% 122.62%
Depreciation & Amortization $7.000M $1.800M $2.100M
YoY Change 6.06% 63.64% 110.0%
% of Gross Profit 6.99% 10.29% 25.0%
Operating Expenses $129.0M $25.90M $25.70M
YoY Change 26.1% 13.1% 19.53%
Operating Profit -$28.90M -$8.400M -$17.30M
YoY Change -48.11% -31.15% 30.0%
Interest Expense $900.0K -$200.0K $0.00
YoY Change 350.0% -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$29.80M -$8.500M -$17.30M
YoY Change -46.59% -30.89% 30.29%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$29.80M -$8.500M -$17.30M
YoY Change -45.32% -30.33% 30.08%
Net Earnings / Revenue -18.63% -25.53% -74.89%
Basic Earnings Per Share
Diluted Earnings Per Share -$419.1K -$122.7K -$250.4K
COMMON SHARES
Basic Shares Outstanding 69.29M shares 69.03M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 2012 Q4 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $54.60M $48.70M $53.34M
YoY Change 12.11% -40.61% -45.18%
Cash & Equivalents $43.20M $8.100M $4.700M
Short-Term Investments $11.40M $40.60M $48.64M
Other Short-Term Assets $3.400M $2.000M $2.700M
YoY Change 70.0% 11.11% 8.0%
Inventory $9.000M $7.400M $7.141M
Prepaid Expenses
Receivables $26.10M $19.50M $12.40M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $93.10M $77.60M $75.57M
YoY Change 19.97% -25.74% -34.4%
LONG-TERM ASSETS
Property, Plant & Equipment $20.70M $18.90M $18.61M
YoY Change 9.52% 26.0% 48.9%
Goodwill $3.200M $3.162M
YoY Change
Intangibles $4.200M $4.313M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.900M $1.100M $98.00K
YoY Change -9.52% 1000.0% -90.2%
Total Long-Term Assets $29.40M $28.40M $27.23M
YoY Change 3.52% 77.5% 100.18%
TOTAL ASSETS
Total Short-Term Assets $93.10M $77.60M $75.57M
Total Long-Term Assets $29.40M $28.40M $27.23M
Total Assets $122.5M $106.0M $102.8M
YoY Change 15.57% -12.03% -20.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.200M $3.900M $3.800M
YoY Change 7.69% 39.29% 40.74%
Accrued Expenses $25.00M $14.00M $15.40M
YoY Change 78.57% 35.92% 48.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.200M $200.0K
YoY Change 1000.0%
Total Short-Term Liabilities $32.10M $19.50M $20.40M
YoY Change 64.62% 32.65% 38.8%
LONG-TERM LIABILITIES
Long-Term Debt $4.600M $6.800M $0.00
YoY Change -32.35%
Other Long-Term Liabilities $1.700M $2.100M $1.570M
YoY Change -37.04% 110.0% 57.0%
Total Long-Term Liabilities $6.300M $2.100M $1.570M
YoY Change -33.68% 110.0% 57.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.10M $19.50M $20.40M
Total Long-Term Liabilities $6.300M $2.100M $1.570M
Total Liabilities $38.40M $29.00M $22.54M
YoY Change 32.41% 81.25% 43.59%
SHAREHOLDERS EQUITY
Retained Earnings -$445.6M -$437.1M
YoY Change 13.94%
Common Stock $522.6M $517.4M
YoY Change 5.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $84.10M $77.00M $80.30M
YoY Change
Total Liabilities & Shareholders Equity $122.5M $106.0M $102.8M
YoY Change 15.57% -12.03% -20.19%

Cashflow Statement

Concept 2013 2012 Q4 2012 Q3
OPERATING ACTIVITIES
Net Income -$29.80M -$8.500M -$17.30M
YoY Change -45.32% -30.33% 30.08%
Depreciation, Depletion And Amortization $7.000M $1.800M $2.100M
YoY Change 6.06% 63.64% 110.0%
Cash From Operating Activities $2.400M -$10.60M -$6.000M
YoY Change -107.25% -7.83% -11.76%
INVESTING ACTIVITIES
Capital Expenditures $7.900M -$1.400M -$2.900M
YoY Change -16.84% -60.0% 93.33%
Acquisitions $0.00
YoY Change
Other Investing Activities $28.80M $8.000M $6.300M
YoY Change -24.01% 7900.0% -169.23%
Cash From Investing Activities $20.90M $6.600M $3.400M
YoY Change -26.41% -288.57% -132.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $12.00M
YoY Change 233.33%
Debt Paid & Issued, Net $200.0K
YoY Change
Cash From Financing Activities $11.80M 7.300M 1.300M
YoY Change 15.69% 7200.0% 44.44%
NET CHANGE
Cash From Operating Activities $2.400M -10.60M -6.000M
Cash From Investing Activities $20.90M 6.600M 3.400M
Cash From Financing Activities $11.80M 7.300M 1.300M
Net Change In Cash $35.10M 3.300M -1.300M
YoY Change 538.18% -122.15% -92.12%
FREE CASH FLOW
Cash From Operating Activities $2.400M -$10.60M -$6.000M
Capital Expenditures $7.900M -$1.400M -$2.900M
Free Cash Flow -$5.500M -$9.200M -$3.100M
YoY Change -87.09% 15.0% -41.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
14100000 USD
CY2012Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
8700000 USD
CY2012Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3900000 USD
CY2013Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4200000 USD
CY2012Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
20700000 USD
CY2013Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
28800000 USD
CY2012Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
19500000 USD
CY2013Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
26100000 USD
CY2012 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-800000 USD
CY2013 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-300000 USD
CY2011 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-900000 USD
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1100000 USD
CY2012Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
800000 USD
CY2012Q4 us-gaap Accrued Vacation Current And Noncurrent
AccruedVacationCurrentAndNoncurrent
2300000 USD
CY2013Q4 us-gaap Accrued Vacation Current And Noncurrent
AccruedVacationCurrentAndNoncurrent
2700000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26600000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21100000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-100000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-100000 USD
CY2012 us-gaap Acquisition Costs
AcquisitionCosts
300000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
522600000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
559500000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24800000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18400000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
106000000 USD
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
400000 USD
CY2011 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
100000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13500000 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18400000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24600000 USD
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13500000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1200000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2700000 USD
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9700000 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9400000 shares
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10400000 shares
CY2013Q4 us-gaap Assets
Assets
122500000 USD
CY2012Q4 us-gaap Assets
Assets
106000000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
93100000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
77600000 USD
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
11400000 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
40600000 USD
CY2013Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
11400000 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
40600000 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
CY2012 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 USD
CY2012 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 USD
CY2012Q4 us-gaap Business Acquisition Equity Interest Issued Or Issuable Value Assigned
BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
3900000 USD
CY2012Q1 us-gaap Business Acquisition Equity Interest Issued Or Issuable Value Assigned
BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
3900000 USD
CY2012Q4 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
1
CY2012Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
6100000 USD
CY2012Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2200000 USD
CY2012Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2200000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43200000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8100000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4900000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2600000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
35100000 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2300000 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5500000 USD
CY2012Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
4500000 USD
CY2013Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
28700000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
54600000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
13000000 shares
CY2013Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12600000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72800000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
69700000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69500000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72500000 shares
CY2012Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
100000 USD
CY2013Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
100000 USD
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44800000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29800000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-54500000 USD
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investment securities, and accounts receivable. We limit our exposure to credit loss by placing our cash with high credit quality financial institutions. We have established guidelines relative to diversification of our cash and investment securities and their maturities that are intended to secure safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates and changes in our operations and financial position. The following table summarizes customers who accounted for </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more of net accounts receivable:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="68%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2012</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer A</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer B</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div>
CY2012 us-gaap Cost Of Revenue
CostOfRevenue
53300000 USD
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
48300000 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
58100000 USD
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
36600000 USD
CY2013 us-gaap Cost Of Revenue
CostOfRevenue
59900000 USD
CY2011 us-gaap Cost Of Revenue
CostOfRevenue
40400000 USD
CY2012Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2016-11-01
CY2012Q4 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
13000000 USD
CY2012 us-gaap Debt Issuance Costs
DebtIssuanceCosts
1100000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
700000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1400000 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
600000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
166000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
152700000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
-100000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
-100000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
132800000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
123500000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
384500000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
273000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5400000 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4500000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
7300000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
5500000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10100000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
12200000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
8100000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
7200000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
151300000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
164700000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1500000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1400000 USD
CY2013 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.90
CY2011 us-gaap Depreciation
Depreciation
3800000 USD
CY2012 us-gaap Depreciation
Depreciation
6100000 USD
CY2013 us-gaap Depreciation
Depreciation
6400000 USD
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6600000 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7000000 USD
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3800000 USD
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.79
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.68
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-160000
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-140000
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-210000
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-80000
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-120000
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-250000
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-40000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-210000
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0007
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0228
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0004
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3500
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3500
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3500
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4515
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3665
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2976
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0711
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0029
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.0213
CY2011 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0237
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0301
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0223
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0008
CY2011 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0202
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0115
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0274
CY2011 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0216
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0270
CY2011 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0393
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0143
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0617
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15100000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9200000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
15100000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
9200000 USD
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
42800000 USD
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
1300000 USD
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1600000 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
100000 USD
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2500000 USD
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
600000 USD
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0 USD
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
2200000 USD
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
1100000 USD
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
0 USD
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1700000 USD
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0 USD
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4200000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
900000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
600000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
300000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
500000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
500000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
700000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3500000 USD
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2500000 USD
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2600000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
3200000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
3200000 USD
CY2012 us-gaap Gross Profit
GrossProfit
46600000 USD
CY2011 us-gaap Gross Profit
GrossProfit
35900000 USD
CY2013 us-gaap Gross Profit
GrossProfit
100100000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
21900000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
8400000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
9400000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
27600000 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
34100000 USD
CY2012Q4 us-gaap Gross Profit
GrossProfit
17500000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
11200000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
16500000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29800000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55800000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44700000 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1300000 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
300000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1000000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2400000 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6500000 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7000000 USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5900000 USD
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5800000 USD
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2400000 USD
CY2011 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1100000 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1200000 USD
CY2012Q4 us-gaap Line Of Credit
LineOfCredit
15000000 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-700000 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
100000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1600000 USD
CY2013 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-300000 USD
CY2012 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
500000 USD
CY2011 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-100000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1400000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
800000 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1200000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4200000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3600000 USD
CY2011 us-gaap Interest And Other Income
InterestAndOtherIncome
100000 USD
CY2013 us-gaap Interest And Other Income
InterestAndOtherIncome
0 USD
CY2012 us-gaap Interest And Other Income
InterestAndOtherIncome
100000 USD
CY2012 us-gaap Interest Expense
InterestExpense
200000 USD
CY2011 us-gaap Interest Expense
InterestExpense
0 USD
CY2013 us-gaap Interest Expense
InterestExpense
900000 USD
CY2011 us-gaap Interest Paid
InterestPaid
0 USD
CY2012 us-gaap Interest Paid
InterestPaid
0 USD
CY2013 us-gaap Interest Paid
InterestPaid
500000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3900000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4500000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
7400000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
9000000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4800000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2500000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
300000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
400000 USD
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
9300000 USD
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
10500000 USD
CY2012Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
700000 USD
CY2013Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
700000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
38400000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
29000000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19500000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32100000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
122500000 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
6800000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2200000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2300000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2300000 USD
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
19000000 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
16200000 USD
CY2013 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Organization and Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring (&#8220;CGM&#8221;) systems for ambulatory use by people with diabetes and by healthcare providers in the hospital for the treatment of people with and without diabetes. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;DexCom&#8221; refer to DexCom, Inc. and its subsidiaries.</font></div></div>
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11800000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
74200000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10200000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46400000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28400000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20900000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2400000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33100000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30100000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-54500000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-29800000 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-44700000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-2600000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-17300000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-14700000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-11100000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-10100000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-14100000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-6000000 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-8500000 USD
CY2011 us-gaap Operating Expenses
OperatingExpenses
80700000 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
102300000 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
129000000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
25700000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
25900000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
27400000 USD
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
24800000 USD
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
25900000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
31800000 USD
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
36400000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
33400000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-55700000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-44800000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-28900000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
8000000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2700000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2600000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2700000 USD
CY2011 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2600000 USD
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
3000000 USD
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2500000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2800000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4800000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1100000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
900000 USD
CY2012 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2013 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2011 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2011 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-100000 USD
CY2013 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2012 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1700000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2100000 USD
CY2011 us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
CY2013 us-gaap Other Noncash Expense
OtherNoncashExpense
200000 USD
CY2012 us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
CY2011 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
0 USD
CY2013 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
0 USD
CY2012 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
6100000 USD
CY2012 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
66400000 USD
CY2013 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
16300000 USD
CY2011 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
102700000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7900000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9500000 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2013Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3400000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2000000 USD
CY2011 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
1200000 USD
CY2012 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
1200000 USD
CY2013 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to the prior period consolidated financial statements and notes to conform to the current year presentation.</font></div></div>
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3600000 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12000000 USD
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
74700000 USD
CY2012 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
6600000 USD
CY2011 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2013 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
45100000 USD
CY2012 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
104300000 USD
CY2011 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
64300000 USD
CY2012 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1900000 USD
CY2013 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3500000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
40000000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47300000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18900000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20700000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1000000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-475400000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-445600000 USD
CY2011 us-gaap Revenues
Revenues
76300000 USD
CY2013 us-gaap Revenues
Revenues
160000000 USD
CY2013Q4 us-gaap Recorded Unconditional Purchase Obligation Due Within One Year
RecordedUnconditionalPurchaseObligationDueWithinOneYear
16200000 USD
CY2013 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
200000 USD
CY2012 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2011 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2011 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
500000 USD
CY2013 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 USD
CY2012 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38300000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44800000 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29600000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1000000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1000000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1000000 USD
CY2012 us-gaap Revenues
Revenues
99900000 USD
CY2013Q1 us-gaap Revenues
Revenues
29600000 USD
CY2013Q2 us-gaap Revenues
Revenues
35800000 USD
CY2013Q3 us-gaap Revenues
Revenues
42900000 USD
CY2012Q2 us-gaap Revenues
Revenues
23500000 USD
CY2012Q3 us-gaap Revenues
Revenues
23100000 USD
CY2013Q4 us-gaap Revenues
Revenues
51700000 USD
CY2012Q1 us-gaap Revenues
Revenues
20100000 USD
CY2012Q4 us-gaap Revenues
Revenues
33300000 USD
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
93000000 USD
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
157100000 USD
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
65900000 USD
CY2012Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
200000 USD
CY2013Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
2200000 USD
CY2013Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
4600000 USD
CY2012Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
6800000 USD
CY2011 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51100000 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
84200000 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64000000 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
18400000 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
13500000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
24600000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3600000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
0.10
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5800000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7910000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2700000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3000000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
29800000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
8180000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
160300000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5900000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7400000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7940000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7670000
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
68960 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
93246 shares
CY2011Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
77466 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
106415 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
89114 shares
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
54408 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6640000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
159100000 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3M18D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M18D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1300000 USD
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3700000 USD
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
5700000 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
5950000
CY2012Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
300000 USD
CY2013Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
900000 USD
CY2011Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
300000 USD
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1500000 shares
CY2012 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
5000000 USD
CY2012 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
2100000 USD
CY2011 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
2200000 USD
CY2013 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
10200000 USD
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1900000 USD
CY2011 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1300000 USD
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1500000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
77000000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
84100000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
104500000 USD
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
61000000 USD
CY2013 us-gaap Tax Credit Carryforward Expiration Date
TaxCreditCarryforwardExpirationDate
2020-01-01
CY2013Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
600000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6200000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4800000 USD
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4400000 USD
CY2010Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3600000 USD
CY2013 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
0 USD
CY2011 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
800000 USD
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
500000 USD
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
900000 USD
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
500000 USD
CY2012 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
100000 USD
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates include excess or obsolete inventories, valuation of inventory, warranty accruals, clinical trial expenses, allowance for bad debt, accounting for the SweetSpot acquisition including contingent consideration, and share-based compensation expense. </font></div></div>
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1300000 USD
CY2011 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 USD
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 USD
CY2011Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
600000 USD
CY2010Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
500000 USD
CY2012Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1200000 USD
CY2013Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
2600000 USD
CY2011 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
700000 USD
CY2012 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
1200000 USD
CY2013 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
2700000 USD
CY2011 us-gaap Valuation Allowances And Reserves Recoveries
ValuationAllowancesAndReservesRecoveries
100000 USD
CY2012 us-gaap Valuation Allowances And Reserves Recoveries
ValuationAllowancesAndReservesRecoveries
100000 USD
CY2013 us-gaap Valuation Allowances And Reserves Recoveries
ValuationAllowancesAndReservesRecoveries
100000 USD
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65600000 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71100000 shares
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68700000 shares
CY2013Q4 dxcm Accounts Receivable Net Of Allowance And Sales Returns Current
AccountsReceivableNetOfAllowanceAndSalesReturnsCurrent
26100000 USD
CY2012Q4 dxcm Accounts Receivable Net Of Allowance And Sales Returns Current
AccountsReceivableNetOfAllowanceAndSalesReturnsCurrent
19500000 USD
CY2013Q4 dxcm Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
1200000 USD
CY2012Q4 dxcm Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
700000 USD
CY2013Q4 dxcm Accrued Wages Bonus And Taxes
AccruedWagesBonusAndTaxes
11300000 USD
CY2012Q4 dxcm Accrued Wages Bonus And Taxes
AccruedWagesBonusAndTaxes
6100000 USD
CY2013Q4 dxcm Acquisition Related Contingent Consideration Short Term
AcquisitionRelatedContingentConsiderationShortTerm
3600000 USD
CY2012Q4 dxcm Acquisition Related Contingent Consideration Short Term
AcquisitionRelatedContingentConsiderationShortTerm
1200000 USD
CY2012 dxcm Business Acquisition Contingent Consideration Settlement
BusinessAcquisitionContingentConsiderationSettlement
1100000 USD
CY2012 dxcm Business Acquisition Contingent Consideration Settlement Shares Issued
BusinessAcquisitionContingentConsiderationSettlementSharesIssued
89296 shares
CY2013Q4 dxcm Business Acquisition Equity Interests Issued Or Issuable Additional Number Of Shares Issuable
BusinessAcquisitionEquityInterestsIssuedOrIssuableAdditionalNumberOfSharesIssuable
267880 shares
CY2012Q1 dxcm Business Combination Contingent Consideration Liability Shares
BusinessCombinationContingentConsiderationLiabilityShares
357176 shares
CY2012Q4 dxcm Clinical Trials
ClinicalTrials
100000 USD
CY2013Q4 dxcm Clinical Trials
ClinicalTrials
300000 USD
CY2012Q4 dxcm Contingent Consideration Fair Value Disclosure
ContingentConsiderationFairValueDisclosure
1700000 USD
CY2013Q4 dxcm Contingent Consideration Fair Value Disclosure
ContingentConsiderationFairValueDisclosure
4200000 USD
CY2012Q4 dxcm Debt Instrument Basis Spread On Treasury Variable Rate
DebtInstrumentBasisSpreadOnTreasuryVariableRate
0.0694
CY2012Q4 dxcm Deferred Tax Assets Goodwill And Intangible Assets Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssetsIntangibleAssets
1000000 USD
CY2013Q4 dxcm Deferred Tax Assets Goodwill And Intangible Assets Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssetsIntangibleAssets
1100000 USD
CY2012 dxcm Development And Other Cost Of Sales
DevelopmentAndOtherCostOfSales
5000000 USD
CY2011 dxcm Development And Other Cost Of Sales
DevelopmentAndOtherCostOfSales
3800000 USD
CY2013 dxcm Development And Other Cost Of Sales
DevelopmentAndOtherCostOfSales
1800000 USD
CY2012 dxcm Development Grant And Other Revenue
DevelopmentGrantAndOtherRevenue
6900000 USD
CY2011 dxcm Development Grant And Other Revenue
DevelopmentGrantAndOtherRevenue
10400000 USD
CY2013 dxcm Development Grant And Other Revenue
DevelopmentGrantAndOtherRevenue
2900000 USD
CY2013 dxcm Employee Purchase Price Floor Percentage
EmployeePurchasePriceFloorPercentage
0.85
CY2012Q4 dxcm Employee Stock Purchase Plan Espp Shares In Espp
EmployeeStockPurchasePlanEsppSharesInEspp
2100000 shares
CY2013Q4 dxcm Employee Stock Purchase Plan Espp Shares In Espp
EmployeeStockPurchasePlanEsppSharesInEspp
2600000 shares
CY2013 dxcm Equity Incentive Plan Grant Date Fair Market Value Floor Percentage
EquityIncentivePlanGrantDateFairMarketValueFloorPercentage
1.00
CY2011 dxcm Fair Value Of Contingent Consideration
FairValueOfContingentConsideration
0 USD
CY2012 dxcm Fair Value Of Contingent Consideration
FairValueOfContingentConsideration
700000 USD
CY2013 dxcm Fair Value Of Contingent Consideration
FairValueOfContingentConsideration
2500000 USD
CY2013Q4 dxcm Finite Lived Intangible Assets Amortization Expenses
FiniteLivedIntangibleAssetsAmortizationExpenses
600000 USD
CY2012Q4 dxcm Finite Lived Intangible Assets Amortization Expenses
FiniteLivedIntangibleAssetsAmortizationExpenses
500000 USD
CY2013 dxcm In Money Options Maximum Exercise Price
InMoneyOptionsMaximumExercisePrice
35.41
CY2013 dxcm Increase Decrease In Restricted Cash Investing And Financing Activities
IncreaseDecreaseInRestrictedCashInvestingAndFinancingActivities
0 USD
CY2012 dxcm Increase Decrease In Restricted Cash Investing And Financing Activities
IncreaseDecreaseInRestrictedCashInvestingAndFinancingActivities
-100000 USD
CY2011 dxcm Increase Decrease In Restricted Cash Investing And Financing Activities
IncreaseDecreaseInRestrictedCashInvestingAndFinancingActivities
800000 USD
CY2013 dxcm Increase In Shares Reserved For Employee Stock Purchase Plan Percentage
IncreaseInSharesReservedForEmployeeStockPurchasePlanPercentage
0.01
CY2013 dxcm Increase In Shares Reserved For Equity Incentive Plans Percentage
IncreaseInSharesReservedForEquityIncentivePlansPercentage
0.03
CY2012Q4 dxcm Line Of Credit Facility Borrowing Base Percentage Of Eligible Accounts
LineOfCreditFacilityBorrowingBasePercentageOfEligibleAccounts
0.80
CY2013 dxcm Maturity Threshold Of Investments Classified To Cash Equivalents
MaturityThresholdOfInvestmentsClassifiedToCashEquivalents
90
CY2013 dxcm Net Operating Losses And Tax Credit Carryforwards Limitations On Use Ownership Change Period
NetOperatingLossesAndTaxCreditCarryforwardsLimitationsOnUseOwnershipChangePeriod
P3Y
CY2013 dxcm Net Operating Losses And Tax Credit Carryforwards Limitations On Use Ownership Changes
NetOperatingLossesAndTaxCreditCarryforwardsLimitationsOnUseOwnershipChanges
0.50
CY2013 dxcm Number Of Purchase Periods Within Offering Period
NumberOfPurchasePeriodsWithinOfferingPeriod
2
CY2013 dxcm Offering Period Months
OfferingPeriodMonths
P12M
CY2013 dxcm Offering Periods Frequency
OfferingPeriodsFrequency
P6M
CY2013 dxcm Option To Renew Lease
OptionToRenewLease
P5Y
CY2013 dxcm Options In Money Exercisable Number
OptionsInMoneyExercisableNumber
5800000 shares
CY2013 dxcm Options In Money Number
OptionsInMoneyNumber
5900000 shares
CY2012 dxcm Permanent Items
PermanentItems
-0.0084
CY2011 dxcm Permanent Items
PermanentItems
-0.0041
CY2013 dxcm Permanent Items
PermanentItems
-0.0364
CY2013 dxcm Potential Rental Rate Adjustment Maximum
PotentialRentalRateAdjustmentMaximum
0.040
CY2013 dxcm Potential Rental Rate Adjustment Minimum
PotentialRentalRateAdjustmentMinimum
0.025
CY2012Q4 dxcm Prime Rate Plus
PrimeRatePlus
0.005
CY2012Q4 dxcm Property Plant And Equipment Computer Equipment
PropertyPlantAndEquipmentComputerEquipment
12000000 USD
CY2013Q4 dxcm Property Plant And Equipment Computer Equipment
PropertyPlantAndEquipmentComputerEquipment
15200000 USD
CY2013 dxcm Purchase Date Frequency Months
PurchaseDateFrequencyMonths
P6M
CY2013 dxcm Purchase Period Months
PurchasePeriodMonths
P6M
CY2013 dxcm Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term
RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm
P1Y
CY2013 dxcm Researchand Development Arrangement Grants Received During Period
ResearchandDevelopmentArrangementGrantsReceivedDuringPeriod
500000 USD
CY2013Q3 dxcm Researchand Development Arrangement Valueof Grant
ResearchandDevelopmentArrangementValueofGrant
4000000 USD
CY2013 dxcm Sales Return Coverage Period
SalesReturnCoveragePeriod
P30D
CY2012Q4 dxcm Share Based Compensation Arrangement By Share Based Payment Award Awards Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardsNonvestedWeightedAverageGrantDateFairValue
5520000
CY2013Q4 dxcm Share Based Compensation Arrangement By Share Based Payment Award Awards Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardsNonvestedWeightedAverageGrantDateFairValue
4600000
CY2013 dxcm Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue
5000000
CY2013 dxcm Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod
200000 shares
CY2013 dxcm Share Based Compensation Excess Tax Benefits
ShareBasedCompensationExcessTaxBenefits
17100000 USD
CY2013Q4 dxcm Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Total Contractual Term
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageTotalContractualTerm
P10Y
CY2013 dxcm Standard Product Warranty Accrual Charges To Costs And Expenses
StandardProductWarrantyAccrualChargesToCostsAndExpenses
4100000 USD
CY2012 dxcm Standard Product Warranty Accrual Charges To Costs And Expenses
StandardProductWarrantyAccrualChargesToCostsAndExpenses
1900000 USD
CY2012Q4 dxcm Stock Options Reserved For Future Grant
StockOptionsReservedForFutureGrant
500000 shares
CY2013Q4 dxcm Stock Options Reserved For Future Grant
StockOptionsReservedForFutureGrant
500000 shares
CY2012Q4 dxcm Term Loan Advances Aggregate Amount
TermLoanAdvancesAggregateAmount
7000000 USD
CY2012Q4 dxcm Term Loan Debt
TermLoanDebt
20000000 USD
CY2013 dxcm Term Of Lease
TermOfLease
P3Y
CY2013 dxcm Unused Expired Federal Income Tax Credits
UnusedExpiredFederalIncomeTaxCredits
2100000 USD
CY2011 dxcm Valuation Allowances And Reserves Write Offs And Adjustments
ValuationAllowancesAndReservesWriteOffsAndAdjustments
-700000 USD
CY2012 dxcm Valuation Allowances And Reserves Write Offs And Adjustments
ValuationAllowancesAndReservesWriteOffsAndAdjustments
-700000 USD
CY2013 dxcm Valuation Allowances And Reserves Write Offs And Adjustments
ValuationAllowancesAndReservesWriteOffsAndAdjustments
-1400000 USD
CY2013Q4 dxcm Working Capital
WorkingCapital
61000000 USD
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001093557
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
72810396 shares
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q2 dei Entity Public Float
EntityPublicFloat
1564116891000 USD
CY2013 dei Entity Registrant Name
EntityRegistrantName
DEXCOM INC
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2013 dei Trading Symbol
TradingSymbol
DXCM

Files In Submission

Name View Source Status
0001093557-14-000028-index-headers.html Edgar Link pending
0001093557-14-000028-index.html Edgar Link pending
0001093557-14-000028.txt Edgar Link pending
0001093557-14-000028-xbrl.zip Edgar Link pending
dxcm-12312013x10k.htm Edgar Link pending
dxcm-20131231.xml Edgar Link completed
dxcm-20131231.xsd Edgar Link pending
dxcm-20131231_cal.xml Edgar Link unprocessable
dxcm-20131231_def.xml Edgar Link unprocessable
dxcm-20131231_lab.xml Edgar Link unprocessable
dxcm-20131231_pre.xml Edgar Link unprocessable
dxcm12312013ex1028.htm Edgar Link pending
dxcm12312013ex1029.htm Edgar Link pending
dxcm12312013ex2101.htm Edgar Link pending
dxcm12312013ex2301.htm Edgar Link pending
dxcm12312013ex3101.htm Edgar Link pending
dxcm12312013ex3102.htm Edgar Link pending
dxcm12312013ex3201.htm Edgar Link pending
dxcm12312013ex3202.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
singledaycontinuousdata.jpg Edgar Link pending